Last reviewed · How we verify
Etilefrin (ETILEFRINE)
Etilefrin (generic name: ETILEFRINE) is a etilefrine drug. It is currently FDA-approved.
Etilefrine is a marketed drug that activates the beta-1 adrenergic receptor to increase heart rate and contractility, positioning it in a competitive landscape alongside other same-class drugs such as isoprenaline, norepinephrine, dopamine, phenylephrine, and dobutamine. A key strength of Etilefrine is its patent protection until 2028, providing a period of exclusivity that could help maintain market share against off-patent competitors. The primary risk is the strong competition from established generics like dopamine and dobutamine, which may limit Etilefrine's market penetration and revenue potential.
At a glance
| Generic name | ETILEFRINE |
|---|---|
| Drug class | etilefrine |
| Target | Beta-1 adrenergic receptor |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- HIgh Versus STAndard Blood Pressure Target in Hypertensive High-risk Patients Undergoing Major Abdominal Surgery (NA)
- Effects of Adding Hypertonic Saline Solutions and/or Etilefrine to Standard Diuretics Therapy in Hepatic Ascites (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Etilefrin CI brief — competitive landscape report
- Etilefrin updates RSS · CI watch RSS
Frequently asked questions about Etilefrin
What is Etilefrin?
What is the generic name of Etilefrin?
What drug class is Etilefrin in?
What development phase is Etilefrin in?
What does Etilefrin target?
Related
- Drug class: All etilefrine drugs
- Target: All drugs targeting Beta-1 adrenergic receptor
- Therapeutic area: All drugs in Cardiovascular
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing